These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12402518)

  • 1. Influence of nitric oxide on the in vitro antiaggregant effect of ticlopidine.
    De La Cruz JP; Arrebola MM; Guerrero A; Sánchez de la Cuesta F
    Vascul Pharmacol; 2002 Mar; 38(3):183-6. PubMed ID: 12402518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils.
    González-Correa JA; Muñoz-Marín J; López-Villodres JA; Navas MD; Guerrero A; Torres JA; De La Cruz JP
    Pharmacol Res; 2007 Aug; 56(2):168-74. PubMed ID: 17644353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway.
    De La Cruz JP; Blanco E; Sánchez de la Cuesta F
    Eur J Pharmacol; 2000 May; 397(1):35-41. PubMed ID: 10844096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of clopidogrel on the platelet-subendothelium interaction, platelet thromboxane and endothelial prostacyclin production, and nitric oxide synthesis.
    Arrebola MM; De la Cruz JP; Villalobos MA; Pinacho A; Guerrero A; Sánchez de la Cuesta F
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):74-82. PubMed ID: 14668571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of glucose concentration on the effects of aspirin, ticlopidine and clopidogrel on platelet function and platelet-subendothelium interaction.
    De La Cruz JP; Arrebola MM; Villalobos MA; Pinacho A; Guerrero A; González-Correa JA; Sánchez de la Cuesta F
    Eur J Pharmacol; 2004 Jan; 484(1):19-27. PubMed ID: 14729378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
    Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans.
    de la Cruz JP; Guerrero A; González-Correa JA; Márquez E; Nacle I; Sánchez de la Cuesta F
    Eur J Clin Pharmacol; 2002 Jan; 57(11):775-80. PubMed ID: 11871383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood.
    González-Correa JA; Arrebola MM; Guerrero A; Muñoz-Marín J; Ruiz-Villafranca D; Sánchez de La Cuesta F; De La Cruz JP
    Platelets; 2005; 16(3-4):171-9. PubMed ID: 16011961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine.
    Farrell TP; Hayes KB; Sobel BE; Schneider DJ
    Am J Cardiol; 1999 Mar; 83(5):770-4. PubMed ID: 10080435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.
    Kawamura M; Imura Y; Moriya N; Kita S; Fukushi H; Sugihara H; Nishikawa K; Terashita Z
    J Pharmacol Exp Ther; 1996 Apr; 277(1):502-10. PubMed ID: 8613960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet and antithrombotic efficacy of SR 121787, a nonpeptide orally active GP IIb/IIIa antagonist, in rabbits: comparison with clopidogrel and aspirin.
    Hoffmann P; Bernat A; Savi P; Herbert JM
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):360-6. PubMed ID: 9300321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation.
    Rupprecht HJ; Darius H; Borkowski U; Voigtländer T; Nowak B; Genth S; Meyer J
    Circulation; 1998 Mar; 97(11):1046-52. PubMed ID: 9531251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of inhibition of nitric oxide synthesis in the aggregation of platelets due to the stimulated production of thromboxane A2.
    Banerjee D; Mazumder S; Sinha AK
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):585-91. PubMed ID: 25083729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ticlopidine or ticlopidine plus aspirin on platelet aggregation and ATP release in normal volunteers: why aspirin improves ticlopidine antiplatelet activity.
    Altman R; Scazziota A; Rouvier J; Gonzalez C
    Clin Appl Thromb Hemost; 1999 Oct; 5(4):243-6. PubMed ID: 10726021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antiplatelet drugs, heparin, and preanalytical variables on platelet function detected by the platelet function analyzer (PFA-100).
    Kottke-Marchant K; Powers JB; Brooks L; Kundu S; Christie DJ
    Clin Appl Thromb Hemost; 1999 Apr; 5(2):122-30. PubMed ID: 10725993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function.
    De Miguel LS; Jiménez A; Montón M; Farré J; Del Mar Arriero M; Rodríguez-Feo JA; García-Cañete J; Rico L; Gómez J; Núñez A; Casado S; Farré AL
    Eur J Clin Invest; 2000 Sep; 30(9):811-7. PubMed ID: 10998082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process.
    Chou TC; Li CY; Yen MH; Ding YA
    Biochem Pharmacol; 1999 Nov; 58(10):1657-63. PubMed ID: 10535758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty.
    Dai H; Chen J; Tao Q; Zhu J; Zhang F; Zheng L; Qiu Y
    Postgrad Med J; 2003 Sep; 79(935):522-6. PubMed ID: 13679549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.